Healthcare Global Enterprises surges as its arm inks pact to acquire 26% stake in EVRE
Healthcare Global Enterprises is currently trading at Rs. 673.15, up by 8.90 points or 1.34% from its previous closing of Rs. 664.25 on the BSE.
The scrip opened at Rs. 677.35 and has touched a high and low of Rs. 677.35 and Rs. 666.10 respectively. So far 1152 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 799.47 on 29-Oct-2025 and a 52 week low of Rs. 513.40 on 30-Mar-2026.
Last one week high and low of the scrip stood at Rs. 708.45 and Rs. 658.35 respectively. The current market cap of the company is Rs. 10041.32 crore.
The promoters holding in the company stood at 64.21%, while Institutions and Non-Institutions held 21.94% and 13.85% respectively.
Healthcare Global Enterprises’ subsidiary -- HCG Manavata Oncology LLP has entered into an agreement to acquire 26% equity stake in Epic Vighnaharta Renewable Energy (EVRE) through subscription of equity shares for an aggregate consideration of Rs 38 lakh.
Following the completion of the acquisition, the HCG Manavata Oncology LLP will hold a 26% stake in EVRE, on a fully diluted basis, and consequently, the company will have an indirect interest of up to 26% in EVRE. The HCG Manavata Oncology LLP would acquire stake in EVRE to qualify as a captive user of the power plant operated by EVRE, so that EVRE can supply the electricity generated by plant to the HCG Manavata Oncology LLP for own use.
The acquisition is expected to be completed in Q2FY2027 upon fulfilment of the terms and conditions stipulated under the agreement executed for the acquisition of stake in EVRE by the LLP.
